Brand-name pricing
Cost, Availability, and Access Pathways: Comparing Branded, Telehealth, and Compounded Semaglutide Access to semaglutide in 2026 reflects a multi-pathway landscape shaped by regulatory frameworks, supply considerations, and cost structures
Orange book: Approved drug products with therapeutic equivalence evaluations
PlexusDx Semaglutide Therapy and Personalized Hypertension Management PlexusDx offers compounded semaglutide injection at $189/mo month-to-month, or from $149/mo on the 6-month plan, delivered to all 50 states without insurance requirements
Acknowledgements The authors acknowledge the support of grants from Inserm, CNRS, Universit Paris Cit, Agence Nationale de la Recherche (ANR), Socit Francophone du Diabte (SFD), Fondation pour la Recherche Mdicale (FRM), the Dutch Organization for Scientific Research (ZonMW) and DiabetesFonds
Experimental studies using GLP-RThave explored how tri-receptor activation influences metabolic signaling across tissues in preclinical systems